Enovix Corporation ENVX
2.87
(0.09)
(3.04%)
as of 25 Sep
- Market cap
- $658.1M
- P/E
- 0.0×
Follow ENVX
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
36.97 | 32.81 | 47.70 | 67.99 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(60.89) | (34.05) | (56.22) | (80.64) | |
P/B ratio |
6.26 | 4.64 | 5.54 | 6.93 | |
Price to Tangible BV |
7.77 | 5.63 | 6.59 | 8.17 | |
EV/Sales |
38.52 | 32.83 | 48.24 | 66.99 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(12.87) | (10.11) | (16.11) | (24.07) | |
EV/FCF |
(11.13) | (8.90) | (13.52) | (17.21) | |
Quick Ratio |
9.19 | 10.47 | 7.94 | 9.30 | |
Current Ratio |
9.71 | 10.97 | 8.34 | 9.72 | |
Net Debt/EBITDA |
(1.68) | (0.02) | (0.48) | 0.81 | |
Debt/Assets |
66.48% | 63.51% | 60.20% | 57.84% | |
Debt/Equity |
2.51 | 2.18 | 1.93 | 1.78 | |
Asset Turnover |
0.06 | 0.05 | 0.05 | 0.04 | |
Operating CF/Net income |
0.51 | 0.86 | 0.77 | 0.48 | |
Capex/Depreciation |
(0.96) | (0.34) | (0.12) | (0.32) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
270.88% | 349.05% | 249.21% | 352.69% | |
Selling, General and Administrative Expense of Revenue |
223.34% | 248.93% | 163.47% | 252.74% | |
Intangible Assets out of Total Assets |
0.05 | 0.05 | 0.05 | 0.05 | |
Share Based Compensation of Revenue |
144.44% | 154.80% | 101.15% | 148.15% | |
Graham Net Nets |
(0.06) | (0.03) | (0.04) | (0.01) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(13.18%) | (15.83%) | (10.40%) | (8.02%) | |
Free Cash Flow Yield |
(9.36%) | (11.25%) | (7.48%) | (5.72%) | |
Revenue per Share |
0.04 | 0.04 | 0.05 | 0.04 | |
Operating CF per Share |
(0.10) | (0.15) | (0.13) | (0.12) | |
Capex per Share |
(0.04) | (0.01) | 0.00 | (0.01) | |
Free Cash Flow per Share |
(0.14) | (0.17) | (0.13) | (0.14) | |
Cash per Share |
2.18 | 2.43 | 2.47 | 2.71 | |
Shareholders Equity per Share |
0.97 | 1.12 | 1.32 | 1.44 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.97 | 1.12 | 1.32 | 1.44 | |
Free Cash Flow |
(31.40) | (36.29) | (28.01) | (28.50) | |
Working Capital |
453.63 | 507.60 | 477.19 | 528.06 | |
Capital Expenditures |
(9.62) | (3.22) | (1.01) | (2.97) | |
Net Current Asset Value |
(81.89) | (32.67) | (62.75) | (27.97) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
1.07 | 0.42 | 0.09 | 0.37 | |
Net Profit Margin |
(477.21%) | (503.42%) | (310.61%) | (672.25%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
3.67 | 3.42 | 4.49 | 3.27 | |
Average Payables |
13.04 | 17.77 | 13.66 | 18.18 | |
Average Inventory |
15.45 | 13.47 | 10.64 | 12.39 | |
Average Assets |
634.37 | 666.47 | 703.07 | 680.87 | |
Average Common Equity |
209.32 | 240.26 | 261.71 | 233.67 |
Columns are period end dates